SK-N-SH（人神經(jīng)母細(xì)胞瘤細(xì)胞）
CBP60744
詢 價(jià)
索取STR
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫
| I. General information | |
| Synonyms: | SK-N-SH |
| Background: | The SK-N-SH line was developed by J.L. Biedler and differs from SK-N-MC (see ATCC HTB-10) in that it exhibits a longer doubling time and higher levels of dopamine - beta - hydroxylase. |
| Species: | Homo sapiens, human |
| Tissue: | brain; derived from metastatic site: bone marrow |
| Disease: | neuroblastoma |
| Gender: | female, 4 years |
| Morphology: | epithelial |
| Growth Mode: | adherent |
| DNA Profile: | Amelogenin: X CSF1PO: 11 D13S317: 11 D16S539: 8,13 D5S818: 12 D7S820: 7,10 THO1: 7,10 TPOX: 8,11 vWA: 14,18 Cobioer’s Cell Line Authentication Service |
| Culture Medium: |
MEM + 10% FBS+ 1% Non Essential Amino Acids (NEAA) + 1mM Sodium Pyruvate (NaP) SK-N-SH完全培養(yǎng)基，# CBP60744M |
| Cryopreservation medium: | 90%FBS+10%DMSO |
| Antigen Expression: | Blood Type A; Rh+ |
| Comments: | plasminogen activator,shows increased expression of M-CSF after treatment with amyloid-beta peptide. For more information, please contact Cobioer (4008-750-250). |
